Xylem (XYL) Q3 2026: Stock Falls 14% on Guidance Cut

Xylem shares fell 14% to a 52-week low after a Q3 2026 revenue miss and a lower full-year outlook, as project delays and cautious utility spending weighed.

Lead

What Did Xylem Report for the Third Quarter?

Xylem reported Q3 revenue of $2.201 billion, down 3.0% from $2.268 billion a year earlier and flat on an organic basis. Adjusted earnings per share rose 5% to $1.44, one cent short of consensus. GAAP EPS rose 34% to $1.25.

Margins improved even as sales stalled. Adjusted EBITDA margin reached 23.9%, up 70 basis points, helped by productivity gains and price realization.

Orders were the strongest part of the report. They rose 7% to about $2.3 billion, or 10% organically, which suggests demand is being booked but is converting to revenue more slowly than expected.

Segment results were mixed:

• Applied Water revenue was $489 million, up 9% organically.
• Water Infrastructure revenue was $645 million, down 1% organically.
• Water Solutions and Services revenue was $631 million, down 2% organically.
• Measurement and Control Solutions, which includes smart metering, was the weakest at $436 million, down 5% organically.

Why Did Xylem Cut Its 2026 Outlook?

Xylem cut its outlook because project timing slipped and utility customers became more cautious about spending. Management also pointed to delayed purchasing decisions on water-metering upgrades and a slower pace of converting demand into sales.

The company now expects 2026 revenue of about $8.95 billion, down 1% year over year, versus its prior forecast of growth of about 2% and a consensus near $9.19 billion. Organic revenue is projected to be flat, down from the earlier 2% to 3% growth range.

Adjusted EPS guidance fell to $5.40-$5.45 from $5.55-$5.70. The adjusted EBITDA margin forecast of about 23.2%, up 100 basis points from 2025, was retained as the main support for earnings, along with a free cash flow margin of about 10.2%.

Why Did the Stock Fall So Sharply?

The stock fell sharply because the guidance cut changed the growth story, not just the quarter. A one-cent EPS miss would not normally trigger a double-digit decline. A revenue shortfall of roughly 3% against consensus, combined with a flat full-year organic outlook, signals that the municipal and utility spending recovery the market had priced in is arriving later than expected.

The result also snapped a run of earnings beats. The reduced outlook fell most heavily on metering and project-driven lines, the areas where investors had looked for the strongest return on utility infrastructure budgets. Strong orders gave only partial offset, since they point to future revenue rather than current sales.

Strategic Context: Portfolio Reshaping

Alongside the results, Xylem said it plans to divest its Applied Water International and Specialty Flow Control businesses. From January 2027 it will report under three segments:

• Treatment and Services, led by Rodney Aulick
• Flow Solutions, led by Joe Johnston
• Measurement and Analytics, led by Meredith Emmerich

CEO Matthew Pine said the company is "moving with urgency to shape Xylem around the markets" where its capabilities deliver the greatest value and growth prospects. The restructuring concentrates the company on treatment, flow and measurement, and removes lower-growth operations from the portfolio.

What Comes Next for Xylem?

The next test is whether the 10% organic order growth converts into revenue in the fourth quarter and 2027. The implied fourth-quarter outlook, together with the divestiture timeline and the January 2027 segment change, will shape how the market values the company.

Outlook

Xylem enters the final quarter of 2026 with rising orders and expanding margins but flat organic sales and a lower earnings base. The stock's move to a 52-week low reflects the gap between booked demand and delivered revenue. Execution on project timing, utility spending decisions and the planned divestitures will set the pace of any recovery.